Congestive cardiac failure (CCF) as a cause of fatal stroke and all cause death

Australian and New Zealand Journal of Medicine

Volumn 28, Issue 6, 1998, Pages 799-804

  Jelinek, M V ^a,b   Ansari, M Z ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Atrial fibrillation; Congestive cardiac failure; Coronary heart disease; Stroke deaths

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STROKE; THROMBOEMBOLISM;

EID: 0032456339     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1998.tb01557.x     Document Type: Article

References (31)

1. Cerebral Embolism Task Force. Cardiogenic brain embolism: second report of the cerebral embolism task force. Arch Neurol 1989; 46C: 727-41.
2. Pop G, Sutherland GR, Koudstaal PJ, Sit TW, dejong G, Roelandt JRTC. Transoesophageal echocardiography in the detection of intracardiac embolie sources in patients with transient ischaemic attacks. Stroke 1990; 21: 560-65.
3. Pearson AC, Labovitz AJ, Tatineni S, Gomez CR. Superiority of transoesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischaemia of uncertain aetiology. JACC 1991; 17: 66-72.
4. Cujec B, Polasek P, Voll C, Shuaib A. Transoesophageal echocardiography in the detection of potential cardiac source of embolism in stroke patients. Stroke 1991; 22: 727-33.
5. Jones EF, Donnan GA, Calafiore P, Tonkin AM. Transoesophageal echocardiography in the investigation of stroke: experience in 135 patients with cerebral ischaemic events. Aust NZ J Med 1993; 23: 477-83.
6. Wolf PA, Dawber TR, Thomas E Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978; 28: 973-7.
7. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. Arch Intern Med 1987; 147: 1561-64.
8. Peterson P, Godtfredson J. Risk factors for stroke in chronic atrial fibrillation. Eur Heart J 1988; 9: 291-4.
9. Peterson P, Boysen G, Godtfredson J, Andersen ED, Anderson B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989; 1: 175-9.
10. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-11.
11. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Final results. Circulation 1991; 84: 527-39.
12. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C, for the CAFA Study Investigators. Canadian Atrial fibrillation anticoagulation (CAFA) study. JACC 1991; 18: 349-55.
13. Ezekowitz MD, Bridgers SL, James KE et al, for the Veterans Affairs Stroke Prevention in non Rheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated with non rheumatic atrial fibrillation. N Engl J Med 1992; 327: 1406-12.
14. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-62.
15. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study. Lancet 1994; 343: 687-91.
16. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation. Arch Intern Med 1994; 154: 1449-57.
17. Jelinek MV, Chow MO, Santamaria J. The low risk cardiac patient: an opportunity for cost containments. J Clin Epidemiol 1994; 47: 1013-20.
18. Berry G, Mandryk J, Mock P. 1986. Presentation of results of logistic regression: analysis of cohort and cross sectional studies. In: Proceedings of Pacific Statistical Conference, Auckland. Francis IS, Manly BFJ, Lam FC (Eds). 1985 Elsevier, Amsterdam: pp 79-82.
19. Breslow NE, Day NE (Eds). Statistical methods in cancer research, Vol. 1. The analysis of case control studies. International agency for Research on Cancer: Lyon, France: IARC Scientific publication No 32, 1980.
20. SYSTAT computer program 1992 inc. Version 5, Evanston, II.
21. Thompson PL, Robinson JS. Stroke after acute myocardial infarction: relation to infarct size Br Med J 1978; 2: 457-9.
22. Johannessen K-A, Nordrehaug JE, Vonderlippe G. Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction. Br Heart J 1984; 51: 553-6.
23. Weinrich FJ, Burke JF, Pauletto FJ. Left ventricular mural thrombi complicating acute myocardial infarction. Long term follow up with serial echocardiography. Ann Intern Med 1984; 100: 789-94.
24. Haugland JM, Asinger RW, Mikell FL, Elsberger J, Hodges M. Embolic potential of left ventricular thrombi detected by two dimensional echocardiography. Circulation 1984; 70: 588-98.
25. Stratton JR, Resnick AD. Increased embolic risk in patients with left ventricular thrombi. Circulation 1987; 75: 1004-11.
26. Jugdutt BI, Sivaram CA, Wortman C, Trudell C, Penner P. Prospective two dimensional echocardiographic evaluation of left ventricular thrombus and embolism after acute myocardial infarction. JACC 1989; 13: 554-64.
27. Vaitkus PT, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta analysis. JACC 1993; 22: 1004-9.
28. Loh E, Sutton M StJ, Wun C-CC et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336: 251-7.
29. Kober L, Torp-Pedersen C, Pedersen OD, Hoilberg S, Camm AJ. Importance of congestive heart failure and interaction of congestive heart failure and left ventricular systolic function on prognosis in patients with acute myocardial infarction. Am J Cardiol 1996; 78: 1124-8.
30. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990; 323: 147-52.
31. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994; 343: 499-503.